Journal of Cancer Research and Therapeutics

ORIGINAL ARTICLE
Year
: 2018  |  Volume : 14  |  Issue : 1  |  Page : 84--89

Preablation neutrophil-to-lymphocyte ratio as an independent prognostic factor in locally advanced hepatocellular carcinoma patients following radiofrequency ablation


Wei Tan1, Wenkui Sun2, Xia Li1, Lei Zhao1, Chun Wang1, Aihua Zang1, Xiangchong Kong1 
1 Department of Ultrasound, Qingdao Municipal Hospital, The Affiliated Hospital of Qingdao University, Qindao, China
2 Department of Ultrasound, Weifang People's Hospital, Weifang, Shandong, China

Correspondence Address:
Dr. Xia Li
Department of Ultrasound, Qingdao Municipal Hospital, The Affiliated Hospital of Qingdao University, 1# Jiaozhou Road, Qindao
China

Background and Aims: Neutrophil-to-lymphocyte ratio (NLR), as an inflammation-based marker, plays critical roles in hepatocellular carcinoma (HCC). This study was aimed to investigate the prognostic value of preablation NLR in locally advanced HCC patients following radiofrequency ablation (RFA) and to determine an optimal cutoff value for NLR. Materials and Methods: From September 2008 to May 2017, 402 locally advanced HCC patients treated with RFA were retrospectively evaluated. Several prognostic factors including NLR was assessed with univariate and multivariate analysis. The optimal cutoff value of NLR was determined with a maximally selected log-rank test. Other prognostic factors influenced the overall survival (OS) were also evaluated. Results: Based on the univariate analysis of 16 prognostic factors for OS, the type of hepatitis, a-fetoprotein (AFP), NLR, alanine aminotransferase, aspartate aminotransferase, and serum albumin were identified as independent prognostic factors; and based on multivariate analysis of 6 prognostic factors for OS, AFP, and NLR were identified (P < 0.05). A NLR of 2.2 was determined to be the optimal cutoff value (area under the curve = 0.855, P < 0.001). In a comparison between the high NLR group and the low NLR group, there was a difference of 7 months in the median OS (24 vs. 31 months, P < 0.001). Conclusions: Preablation NLR was a valuable predictor in locally advanced HCC patients treated with RFA. NLR ≥2.2 indicated a poor prognosis. These findings suggested that preablation NLR may be a convenient, easily-obtained, low cost, and reliable biomarker with prognostic potential for HCC patients.


How to cite this article:
Tan W, Sun W, Li X, Zhao L, Wang C, Zang A, Kong X. Preablation neutrophil-to-lymphocyte ratio as an independent prognostic factor in locally advanced hepatocellular carcinoma patients following radiofrequency ablation.J Can Res Ther 2018;14:84-89


How to cite this URL:
Tan W, Sun W, Li X, Zhao L, Wang C, Zang A, Kong X. Preablation neutrophil-to-lymphocyte ratio as an independent prognostic factor in locally advanced hepatocellular carcinoma patients following radiofrequency ablation. J Can Res Ther [serial online] 2018 [cited 2022 Oct 5 ];14:84-89
Available from: https://www.cancerjournal.net/article.asp?issn=0973-1482;year=2018;volume=14;issue=1;spage=84;epage=89;aulast=Tan;type=0